David Denning: Rapid spread of mucormycosis amongst COVID patients in India.

• Leading global fungal infection charity GAFFI has issued guidelines to help patients and carers manage the condition

Multiple reports from India have identified the otherwise rare fungal infection mucormycosis affecting many patients and leaving major disfigurement or death. High numbers have been seen in Gujrat, Maharastra, Karnataka, Tamil Nadu, Andhra Pradesh, Delhi, Chandigarh and Punjab but very few cases in the eastern part of India.